ClinicalTrials.gg
RecruitingNCT07325604Updated Mar 9, 2026

Effect of Neuromuscular Electrical Stimulation on Unilateral Central Facial Palsy

An interventional study of Neuromuscular electrical stimulation (NMES) and Usual Care in Facial Palsy and Stroke, sponsored by University of Aarhus. Recruiting at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-09.

Sponsored by University of Aarhus · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Feb 2026; still recruiting 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
130
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Background Central facial palsy (CFP) is a common condition in stroke, with an estimated prevalence of 45%. CFP can lead to facial asymmetry, problems with mouth closure and food processing, bite marks on the cheek, social isolation, and reduced quality of life. CFP is seen as an important area of rehabilitation, and training is therefore often carried out to reduce the consequences of CFP. In a recent systematic review conducted by the principal investigator, the results showed that very few studies have been conducted that have investigated the effect of training for CFP, and there is currently no scientific evidence to support the effect of the various training interventions.

Objective To investigate the effect of Neuromuscular electrical stimulation (NMES) on facial symmetry compared to usual practice, in participants with CFP as a result of stroke.

Hypothesis: Participants who receive training with NMES together with usual training for facial paralysis have greater improvement in facial symmetry than participants who only receive usual training for facial paralysis.

Trial design Randomized controlled trial (RCT) with a nested pilot trial. A pilot trial/RCT will be conducted in order to power calculation in an RCT. The protocol for the pilot trial and RCT will be the same, and participants from the pilot trial and their outcome data are thus expected to be included in the RCT.

02

Conditions studied

  • Facial Palsy
  • Stroke

Keywords

  • NMES
  • Central facial palsy
  • Multicenter RCT
  • Stroke
  • Facial symmetry
03

In context

Facial Paralysis

81 studies on the registry are indexed under Facial Paralysis; 28 are open to participants now.

This study's planned enrollment of 130 is above the median of 50 across 59 interventional studies indexed under Facial Paralysis.

Browse Facial Paralysis studies →

Lead sponsor

University of Aarhus is the lead sponsor of 1,300 studies on the registry; 189 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Central facial palsy
  • First time stroke
  • >=18 years
  • Able to provide written consent

Exclusion criteria

Exclusion Criteria:

  • Not able to cooperate for mimical exercises
  • for NMES
  • Admitted for three weeks assessment stay at the hospital
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
130 participants (estimated)

Study arms

  • Experimental
    NMES

    NMES is provided as an add-on to usual care

    Device: Neuromuscular electrical stimulation (NMES) · Other: Usual Care

  • Active comparator
    Usual care

    This arm receives usual care of facial palsy without NMES. Usual care encompass mimical exercises, facio oral sensory input, and kinesio taping.

    Other: Usual Care

Interventions

  • DeviceNeuromuscular electrical stimulation (NMES)

    Electrical stimulation of facial muscles.

  • OtherUsual Care

    This arm receives usual care of facial palsy without NMES. Usual care encompass mimical exercises, facio oral sensory input, and kinesio taping.

06

What researchers measure

Primary outcomes

  1. My Facial Quantification (MyFacialQ)

    MyFacialQ quantifies degree of unilateral facial palsy through video recordings of mimical exercises. The development and validation study for MyFacialQ is in review.

    Time frame: From enrollment to the end of treatment at four weeks"

Secondary outcomes

  1. Iowa Oral Performance Instrument (IOPI)

    Measurement of lip strength

    Time frame: From enrollment to the end of treatment at four weeks

  2. Facial Clinimetric Evaluation (FACE)

    Patient reported outcome on facial palsy

    Time frame: From enrollment to three months follow-up after the intervention

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — IPD raw data is mainly video recordings, and these will not be shared. However aggregated measures from the video recordings may be shared.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07325604
Collaborators
Danish Association of Occupational Therapist, Hammel Neurorehabilitation Centre and University Research Clinic, Hospital of Central Denmark Region, Denmark
Responsible party
Sponsor
First posted
Jan 8, 2026
Start date
Feb 27, 2026
Primary completion
Dec 15, 2030 (estimated)
Completion
Dec 15, 2030 (estimated)
Last update
Mar 9, 2026

Study contacts

Jesper Fabricius, PhD
Contact
jesperjm@hotmail.com
+4578419051
Jesper Fabricius, PhD
principal investigator · Hammel Neurorehabilitation Centre and University Research Clinic & Department of clinical medicine, Aarhus University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion